Former JHL Biotech Inc. CEO Racho Jordanov and former Chief Operating Officer Rose Lin were sentenced for their respective roles in conspiring to commit trade secret theft and wire fraud exceeding $101 million. The pair last summer admitted to obtaining confidential, proprietary, and trade-secret information from Roche Holding AG’s Genentech Inc. unit and using what they stole to reduce expenses and hasten the timeline of JHL’s efforts to develop biosimilars. Read More
SCG Cell Therapy Pte. Ltd. has signed a collaboration agreement with Singapore’s Agency for Science, Technology and Research (A*STAR)’s Bioprocessing Technology Institute (BTI) to advance the development of multispecific antibodies. Read More
Shanghai Junshi Biosciences Co. Ltd. and Coherus Biosciences Inc. have disclosed positive data from a phase III trial of the anti-PD-1 antibody toripalimab in combination with chemotherapy in China. Read More
With the World Health Organization’s COVAX facility having more COVID-19 vaccine doses available than have been requested by the countries it was designed to help, industry groups are pushing back against the proposed TRIPS waiver for COVID-19 vaccines. Read More
Edigene Inc. has obtained nonexclusive, global rights to technology from Boston Children’s Hospital for technology related to increasing fetal hemoglobin levels by disrupting B-cell lymphoma/leukemia 11A (BCL11A) expression at the genomic level to treat hemoglobinopathies. Read More
As it settles a patent dispute with Japan’s Chugai Pharmaceutical Co. for $775 million, the U.K.’s Astrazeneca plc is looking to bring intellectual property in-house by snapping up a new generation of talented scientists. Read More
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adamis, Ascentage, Astellas, Biogen, Biontech, Cansino, Clover, Codagenix, Coherus, Cstone, Dr. Reddy's, Eiger, Eisai, Ena Respiratory, Faron, Journey Medical, Junshi, Ose Immunotherapeutics, Paradigm, Pfizer. Read More
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Akston, Ascletis, Bavarian Nordic, Biogen, Biolexis, Boston Children’s Hospital, Edigene, Eisai, Imugene, Innovation, Kukbo, Linkinvax, Lynk, Merck, Moderna, Nanomerics, Nuance, Pfizer, Pharmabcine, Redhill, Rnagene, Scripps Research, Simcere, Soligenix, Sorrento, Virpax, Washington University. Read More
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Adagene, AIDS Clinical Trials Group, Astrazeneca, Beigene, Bioheng, Biontech, Brii, Cstone, Medison, Moderna, Pfizer, Shionogi, Sinomab, Swedish Orphan Biovitrum. Read More
